StockNews.com Begins Coverage on CVS Health (NYSE:CVS)

Analysts at StockNews.com started coverage on shares of CVS Health (NYSE:CVS – Get Rating) in a research report issued on Thursday. The firm set a “buy” rating on the pharmacy operator’s stock.

A number of other brokerages also recently weighed in on CVS. Wells Fargo & Company dropped their target price on shares of CVS Health from $106.00 to $101.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 3rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $115.00 target price on shares of CVS Health in a research note on Thursday, February 9th. Credit Suisse Group boosted their price target on shares of CVS Health from $117.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, November 21st. Barclays dropped their price target on shares of CVS Health from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Thursday, February 9th. Finally, Jefferies Financial Group boosted their price target on shares of CVS Health from $130.00 to $143.00 and gave the stock a “buy” rating in a research note on Thursday, February 9th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $119.65.

CVS Health Price Performance

NYSE:CVS opened at $75.40 on Thursday. The firm has a market cap of $96.82 billion, a PE ratio of 24.17, a price-to-earnings-growth ratio of 1.19 and a beta of 0.65. CVS Health has a 12 month low of $74.52 and a 12 month high of $109.69. The company has a quick ratio of 0.67, a current ratio of 0.94 and a debt-to-equity ratio of 0.71. The company’s 50-day moving average price is $86.04 and its two-hundred day moving average price is $93.35.

CVS Health (NYSE:CVS – Get Rating) last announced its earnings results on Wednesday, February 8th. The pharmacy operator reported $1.99 earnings per share for the quarter, topping analysts’ consensus estimates of $1.92 by $0.07. CVS Health had a net margin of 1.29% and a return on equity of 15.75%. The company had revenue of $83.85 billion during the quarter, compared to the consensus estimate of $76.37 billion. During the same period in the previous year, the firm posted $1.98 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. On average, equities analysts anticipate that CVS Health will post 8.84 EPS for the current fiscal year.

Institutional Investors Weigh In On CVS Health

Several large investors have recently bought and sold shares of CVS. Cantor Fitzgerald Investment Advisor L.P boosted its holdings in shares of CVS Health by 92.9% in the first quarter. Cantor Fitzgerald Investment Advisor L.P now owns 377,875 shares of the pharmacy operator’s stock valued at $38,245,000 after buying an additional 181,966 shares during the period. United Bank boosted its holdings in shares of CVS Health by 7.2% in the first quarter. United Bank now owns 18,658 shares of the pharmacy operator’s stock valued at $1,888,000 after buying an additional 1,260 shares during the period. Loomis Sayles & Co. L P boosted its holdings in shares of CVS Health by 4,063.8% in the first quarter. Loomis Sayles & Co. L P now owns 12,075 shares of the pharmacy operator’s stock valued at $1,222,000 after buying an additional 11,785 shares during the period. Zions Bancorporation N.A. boosted its holdings in shares of CVS Health by 116.9% in the first quarter. Zions Bancorporation N.A. now owns 2,572 shares of the pharmacy operator’s stock valued at $260,000 after buying an additional 1,386 shares during the period. Finally, Ergoteles LLC acquired a new position in shares of CVS Health in the first quarter valued at approximately $1,551,000. Institutional investors own 77.29% of the company’s stock.

CVS Health Company Profile

(Get Rating)

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Pharmacy Services, Retail or Long-Term Care, Health Care Benefits, and Corporate and Other. The Pharmacy Services segment focuses on the pharmacy benefit management solutions.